CN107478757B - Purification and preparation method of ketamine standard substance for forensic drug detection - Google Patents
Purification and preparation method of ketamine standard substance for forensic drug detection Download PDFInfo
- Publication number
- CN107478757B CN107478757B CN201710316040.0A CN201710316040A CN107478757B CN 107478757 B CN107478757 B CN 107478757B CN 201710316040 A CN201710316040 A CN 201710316040A CN 107478757 B CN107478757 B CN 107478757B
- Authority
- CN
- China
- Prior art keywords
- ketamine
- sample
- methanol
- standard
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 title claims abstract description 130
- 229960003299 ketamine Drugs 0.000 title claims abstract description 129
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 239000000126 substance Substances 0.000 title claims abstract description 30
- 229940079593 drug Drugs 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 238000001514 detection method Methods 0.000 title claims abstract description 18
- 238000000746 purification Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 14
- 238000004811 liquid chromatography Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 132
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 239000000523 sample Substances 0.000 claims description 36
- 239000012071 phase Substances 0.000 claims description 27
- 239000012488 sample solution Substances 0.000 claims description 22
- 238000005259 measurement Methods 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 229960004184 ketamine hydrochloride Drugs 0.000 claims description 14
- UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
- 238000010829 isocratic elution Methods 0.000 claims description 9
- 239000012074 organic phase Substances 0.000 claims description 9
- 238000000825 ultraviolet detection Methods 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 239000013078 crystal Substances 0.000 claims description 6
- 239000012982 microporous membrane Substances 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000013558 reference substance Substances 0.000 claims description 6
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 5
- 238000010812 external standard method Methods 0.000 claims description 4
- 238000002953 preparative HPLC Methods 0.000 claims description 4
- 238000002390 rotary evaporation Methods 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000004451 qualitative analysis Methods 0.000 claims description 3
- 238000004445 quantitative analysis Methods 0.000 claims description 3
- 239000011550 stock solution Substances 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 19
- 238000004458 analytical method Methods 0.000 abstract description 8
- 238000005481 NMR spectroscopy Methods 0.000 abstract description 4
- 238000002329 infrared spectrum Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 abstract description 3
- 238000004817 gas chromatography Methods 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 238000004007 reversed phase HPLC Methods 0.000 description 9
- 239000000550 preparative sample Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 4
- XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000012925 reference material Substances 0.000 description 3
- 238000002211 ultraviolet spectrum Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- FGDQGIKMWOAFIK-UHFFFAOYSA-N acetonitrile;phosphoric acid Chemical compound CC#N.OP(O)(O)=O FGDQGIKMWOAFIK-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003255 drug test Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- VCMGMSHEPQENPE-UHFFFAOYSA-N ketamine hydrochloride Chemical compound [Cl-].C=1C=CC=C(Cl)C=1C1([NH2+]C)CCCCC1=O VCMGMSHEPQENPE-UHFFFAOYSA-N 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000337 buffer salt Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- UHNSRFWQBVXBSK-UHFFFAOYSA-N methanol;2,2,2-trifluoroacetic acid Chemical compound OC.OC(=O)C(F)(F)F UHNSRFWQBVXBSK-UHFFFAOYSA-N 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004262 preparative liquid chromatography Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010966 qNMR Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/14—Preparation by elimination of some components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/08—Preparation using an enricher
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/89—Inverse chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/08—Preparation using an enricher
- G01N2030/085—Preparation using an enricher using absorbing precolumn
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开用于法庭科学毒品检测的氯胺酮标准物质的纯化制备方法,包括如下步骤:(1)检测缴获氯胺酮样品中氯胺酮的纯度,选择氯胺酮质量分数大于或等于50wt%的缴获氯胺酮样品作为纯化制备氯胺酮标准物质的原料;(2)利用高效液相色谱制备氯胺酮标准物质。本发明制备纯化方法得到的氯胺酮经核磁共振、液相色谱‑串联质谱联用、红外光谱分析确认,其纯度经液相色谱、气相色谱确认定值,并对色谱无响应杂质进行测定;根据标准物质研制要求,其稳定性、均匀性、定值、总不确定度的估计均符合相关规定,达到预期指标。
The invention discloses a method for purifying and preparing a ketamine standard substance used in forensic drug detection, comprising the following steps: (1) detecting the purity of ketamine in a seized ketamine sample, and selecting a seized ketamine sample whose mass fraction of ketamine is greater than or equal to 50 wt % as the purified preparation The raw material of ketamine standard substance; (2) utilize high performance liquid chromatography to prepare ketamine standard substance. The ketamine obtained by the preparation and purification method of the present invention is confirmed by nuclear magnetic resonance, liquid chromatography-tandem mass spectrometry, and infrared spectrum analysis, and its purity is determined by liquid chromatography and gas chromatography, and the chromatographic non-responsive impurities are measured; according to the standard The material development requirements, its stability, uniformity, definite value, and estimation of total uncertainty all meet the relevant regulations and meet the expected indicators.
Description
技术领域technical field
本发明涉及法庭科学毒品标准品的制备。更具体地,涉及一种用于法庭科学毒品检测的氯胺酮标准物质的纯化制备方法。The invention relates to the preparation of forensic science drug standard products. More specifically, it relates to a method for purifying and preparing ketamine standard substances used in forensic drug detection.
背景技术Background technique
目前,日趋严重的毒品问题已成为全球性的灾难。毒品的泛滥直接危害人民的身心健康,并给经济发展和社会进步带来巨大威胁。因此,建立法庭科学毒品检测量值溯源体系,提高毒品成份量测量技术,保证测量结果的可靠性和可比性,建立测量数据的共享与互认,为法庭提供准确可靠的证据,已成为世界各国毒品鉴定机构普遍关注的问题。At present, the increasingly serious drug problem has become a global disaster. The proliferation of drugs directly endangers people's physical and mental health, and poses a huge threat to economic development and social progress. Therefore, establishing a forensic scientific drug detection quantity traceability system, improving the measurement technology of drug components, ensuring the reliability and comparability of measurement results, establishing the sharing and mutual recognition of measurement data, and providing accurate and reliable evidence for courts has become a national standard in the world. A general concern of drug identification agencies.
毒品成份量测量技术及溯源性保障是一个有机的整体,是核心测量能力在法庭科学毒品成份量测量领域的重要体现。标准物质是贯穿于这个整体的骨架,是量值的载体,是毒品成份量溯源体系的关键要素,是保证测量结果在时间和空间上的准确性和可比性的重要基础,是实现有效测量即准确、可比、可溯源测量的根本保证。Drug composition measurement technology and traceability guarantee are an organic whole, which is an important embodiment of core measurement capabilities in the field of forensic drug composition measurement. The reference material is the skeleton that runs through the whole, the carrier of the quantity value, the key element of the traceability system of drug ingredients, the important basis for ensuring the accuracy and comparability of the measurement results in time and space, and the realization of effective measurement that is The fundamental guarantee for accurate, comparable and traceable measurements.
欧美等国家技术先进的毒品检测实验室大多采用Sigma等公司生产的国际上公认的标准物质,但在我国只能依赖进口的标准物质,量少价高,有许多还不能向中国提供。目前国内毒品分析中使用的“对照品”不仅种类极为有限,而且普遍缺乏完善的结构鉴定、纯度测定、均匀性和稳定性等相应的技术指标。这些都给涉毒案件检测带来一定的不确定性,直接影响到定量结果的准确性。而且,国内毒品标准物质的匮乏,已经成为制约我国实现法庭科学毒品检测化学测量方法标准化、测量结果的溯源和互认的主要障碍。因此,能够制备出用于法庭科学毒品检测的毒品标准物质已经成为我国毒品研究领域亟需解决的问题。Most of the advanced drug testing laboratories in Europe and the United States use internationally recognized reference materials produced by companies such as Sigma, but in my country we can only rely on imported reference materials, which are small in quantity and high in price, and many of them cannot be provided to China. At present, the types of "reference substances" used in domestic drug analysis are not only extremely limited, but also generally lack corresponding technical indicators such as perfect structure identification, purity determination, uniformity and stability. All of these bring certain uncertainties to the detection of drug-related cases and directly affect the accuracy of quantitative results. Moreover, the lack of domestic drug standard substances has become a major obstacle restricting my country from realizing the standardization of forensic drug detection chemical measurement methods, traceability and mutual recognition of measurement results. Therefore, the ability to prepare drug reference substances for forensic drug detection has become an urgent problem in the field of drug research in my country.
氯胺酮的英文通用名称:(±)-Ketamine hydrochloride,化学名称:2-邻氯苯基-2-四氨基-环已酮盐酸盐,英文名称:(±)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride,分子式:C13H16ClNO·HCl,分子量:274.19,CA登记号:1867-66-9,结构式为:Ketamine’s English common name: (±)-Ketamine hydrochloride, chemical name: 2-o-chlorophenyl-2-tetraamino-cyclohexanone hydrochloride, English name: (±)-2-(2-Chlorophenyl)- 2-(methylamino)cyclohexanone hydrochloride, molecular formula: C 13 H 16 ClNO·HCl, molecular weight: 274.19, CA registration number: 1867-66-9, structural formula:
理化性质:白色结晶性粉末,无臭。易溶于水(200mg/mL),溶于热乙醇,不溶于乙醚和苯。熔点为259-263℃。水溶液呈酸性,pH值4.0~5.5。Physical and chemical properties: white crystalline powder, odorless. Soluble in water (200mg/mL), soluble in hot ethanol, insoluble in ether and benzene. The melting point is 259-263°C. The aqueous solution is acidic, with a pH value of 4.0-5.5.
发明内容Contents of the invention
本发明的一个目的在于提供一种用于法庭科学毒品检测的氯胺酮标准物质的纯化制备方法。An object of the present invention is to provide a method for purifying and preparing ketamine standard substances used in forensic drug testing.
为达到上述目的,本发明采用下述技术方案:To achieve the above object, the present invention adopts the following technical solutions:
用于法庭科学毒品检测的氯胺酮标准物质的纯化制备方法,包括如下步骤:(1)检测缴获氯胺酮样品中氯胺酮的纯度,选择氯胺酮质量分数大于或等于50wt%的缴获氯胺酮样品作为纯化制备氯胺酮标准物质的原料;The method for purifying and preparing a ketamine standard substance for forensic drug detection comprises the following steps: (1) detecting the purity of ketamine in a seized ketamine sample, and selecting a seized ketamine sample whose mass fraction of ketamine is greater than or equal to 50wt% as a purified ketamine standard substance raw materials;
(2)利用高效液相色谱制备氯胺酮标准物质。(2) Preparation of ketamine standard substance by high performance liquid chromatography.
上述用于法庭科学毒品检测的氯胺酮标准物质的纯化制备方法,在步骤(1)中,包括如下步骤:The above-mentioned purification preparation method for the ketamine standard substance used for forensic science drug detection, in step (1), comprises the following steps:
(1.1)样品溶液的制备:1.0mg氯胺酮样品溶于1mL甲醇中,配成1.0mg/mL氯胺酮样品溶液用于定性及定量分析,使用前样品溶液经过0.45μm微孔滤膜过滤;(1.1) Preparation of sample solution: 1.0mg ketamine sample was dissolved in 1mL methanol to prepare 1.0mg/mL ketamine sample solution for qualitative and quantitative analysis. Before use, the sample solution was filtered through a 0.45 μm microporous membrane;
(1.2)确定液相色谱条件:色谱柱为Shim-pack HRC-ODS柱,250mm×4.6mm I.D.,5μm;流动相为V甲醇:V0.05%三氟乙酸/水=(33-35):(65-67),等度洗脱;紫外检测波长210nm;流速1.0mL/min;柱温35℃;(1.2) Determine liquid chromatography condition: chromatographic column is Shim-pack HRC-ODS post, 250mm * 4.6mm ID, 5 μ m; Mobile phase is V methanol : V 0.05% trifluoroacetic acid/water =(33-35):( 65-67), isocratic elution; UV detection wavelength 210nm; flow rate 1.0mL/min; column temperature 35°C;
(1.3)计算标准曲线的回归方程及确定线性范围:用色谱纯甲醇稀释氯胺酮标准储备液,精密配制成浓度分别为0.5、1、5、10、50、100、500、1000μg/mL的氯胺酮对照品溶液,按步骤(1.2)中的反相色谱条件测定,每个浓度重复3次,以平均值计算,记录氯胺酮色谱峰面积,以对照品的进样浓度为横坐标,浓度为μg/mL,色谱峰面积值为纵坐标作图,并计算标准曲线的回归方程;以峰面积对浓度作图,标准曲线的回归方程为:(1.3) Calculate the regression equation of the standard curve and determine the linear range: dilute the ketamine standard stock solution with chromatographically pure methanol, and precisely prepare ketamine controls with concentrations of 0.5, 1, 5, 10, 50, 100, 500, and 1000 μg/mL Product solution, measured by the reversed-phase chromatographic conditions in step (1.2), each concentration was repeated 3 times, calculated with the average value, and recorded the ketamine chromatographic peak area, taking the injection concentration of the reference substance as the abscissa, and the concentration is μg/mL , the chromatographic peak area value is plotted on the ordinate, and calculates the regression equation of the standard curve; plots the concentration with the peak area, and the regression equation of the standard curve is:
Y=3×107X+92617,R2=0.9999,Y=3×10 7 X+92617, R 2 =0.9999,
氯胺酮在0.5--1000μg/mL的范围内线性关系良好;Ketamine has a good linear relationship in the range of 0.5--1000μg/mL;
(1.4)按步骤(1.2)中的反相色谱方法分析测定浓度为1.0mg/mL的氯胺酮样品溶液,重复测定3次,记录氯胺酮峰面积,计算其平均值,按峰面积外标法计算样品中的氯胺酮含量。(1.4) Analyze and measure the ketamine sample solution whose concentration is 1.0 mg/mL according to the reverse phase chromatography method in step (1.2), repeat the measurement 3 times, record the peak area of ketamine, calculate its average value, and calculate the sample by the peak area external standard method ketamine content in .
上述用于法庭科学毒品检测的氯胺酮标准物质的纯化制备方法,在步骤(2)中,包括如下步骤:The above-mentioned purification preparation method for the ketamine standard substance used for forensic science drug detection, in step (2), comprises the following steps:
(2.1)样品溶液的制备:3.369g氯胺酮样品先溶于10mL甲醇中,充分溶解后离心,过滤去除沉淀,有机相取出,离心浓缩至干,加水定容至10mL,配成氯胺酮样品溶液用于制备型高效液相色谱分离制备氯胺酮标准品,使用前样品溶液经过0.45μm微孔滤膜过滤;(2.1) Preparation of sample solution: Dissolve 3.369g of ketamine sample in 10mL of methanol first, centrifuge after fully dissolving, filter to remove precipitate, take out the organic phase, concentrate to dryness by centrifugation, add water to make up to 10mL, and prepare ketamine sample solution for use in Preparative high-performance liquid chromatography was used to separate and prepare ketamine standard products, and the sample solution was filtered through a 0.45 μm microporous membrane before use;
(2.2)确定液相色谱条件:(2.2) Determine liquid chromatography conditions:
(2.2.1)色谱柱为Shim-pack VP-ODS制备柱(250mm×20mm I.D.,15μm);流动相为V甲醇:V水=30:70,甲醇和水充分混匀脱气后使用,等度洗脱;紫外检测波长210nm;流速8mL/min;上样量700μL;柱温为室温;运行20分钟后以100%甲醇冲洗色谱柱;或者(2.2.1) The chromatographic column is a Shim-pack VP-ODS preparative column (250mm×20mm ID, 15μm); the mobile phase is V methanol : V water = 30:70, methanol and water are fully mixed and degassed before use, etc. Ultraviolet detection wavelength 210nm; flow rate 8mL/min; sample volume 700μL; column temperature at room temperature; wash the column with 100% methanol after running for 20 minutes; or
(2.2.2)色谱柱为Shim-pack VP-ODS制备柱(250mm×20mm I.D.,15μm);流动相为V甲醇:V0.05%三氟乙酸/水=20:80,等度洗脱;紫外检测波长210nm;流速8mL/min;上样量500μL;柱温为室温;(2.2.2) The chromatographic column is a Shim-pack VP-ODS preparative column (250mm×20mm ID, 15 μm); the mobile phase is V methanol : V 0.05% trifluoroacetic acid/water =20:80, isocratic elution; UV The detection wavelength is 210nm; the flow rate is 8mL/min; the sample volume is 500μL; the column temperature is room temperature;
(2.3)在采用步骤(2.2.2)中的色谱条件下,将收集到的馏分经旋蒸除去甲醇后,调节剩余的水溶液pH至11,以色谱纯氯仿提取,合并有机相,离心浓缩至出现白色沉淀,向其中注入水,缓慢加入0.1N盐酸至水液pH至5-6,去除其中有机相,水相冷冻干燥后即可获得盐酸氯胺酮晶体。(2.3) Under the chromatographic conditions in the step (2.2.2), after the collected fractions are removed by rotary evaporation, the pH of the remaining aqueous solution is adjusted to 11, extracted with chromatographically pure chloroform, the organic phases are combined, and concentrated by centrifugation to A white precipitate appears, inject water into it, slowly add 0.1N hydrochloric acid until the pH of the aqueous solution reaches 5-6, remove the organic phase, and freeze-dry the aqueous phase to obtain ketamine hydrochloride crystals.
本发明的有益效果如下:The beneficial effects of the present invention are as follows:
本发明制备纯化方法得到的氯胺酮晶体中,按照高效液相色谱峰面积归一化法计算氯胺酮纯度大于或等于99.1wt%。In the ketamine crystals obtained by the preparation and purification method of the present invention, the purity of ketamine calculated according to the peak area normalization method of high performance liquid chromatography is greater than or equal to 99.1 wt%.
本发明制备纯化方法得到的氯胺酮经核磁共振、液相色谱-串联质谱联用、红外光谱分析确认,其纯度经液相色谱、气相色谱确认定值,并对色谱无响应杂质进行测定;根据标准物质研制要求,其稳定性、均匀性、定值、总不确定度的估计均符合相关规定,达到预期指标。The ketamine obtained by the preparation and purification method of the present invention is confirmed by nuclear magnetic resonance, liquid chromatography-tandem mass spectrometry, and infrared spectrum analysis, and its purity is determined by liquid chromatography and gas chromatography, and the chromatographic non-responsive impurities are measured; The material development requirements, its stability, uniformity, definite value, and estimation of total uncertainty all meet the relevant regulations and meet the expected indicators.
本发明的制备纯化方法可为我国司法鉴定部门提供量值准确、可溯源的氯胺酮标准物质,填补我国法庭科学领域毒品标准物质空白,以改进分析测量质量,提高定量结果的准确度,最大程度地保证测量结果的有效性。有助于建立法庭科学毒品检测量值溯源体系,有利于实现国内法庭科学毒品检测化学测量方法标准化,实现测量结果的可靠、有效和互认。The preparation and purification method of the present invention can provide accurate and traceable ketamine standard substances for judicial appraisal departments in my country, fill in the blank of drug standard substances in the field of forensic science in my country, improve the quality of analysis and measurement, improve the accuracy of quantitative results, and maximize the Guarantee the validity of the measurement results. It is helpful to establish a traceability system for forensic science drug detection quantity, is conducive to the standardization of domestic forensic science drug detection chemical measurement methods, and realizes the reliability, effectiveness and mutual recognition of measurement results.
克服了现有技术制备纯化方法得到的氯胺酮样品存在的纯度低、稳定性差、均匀性差、制备过程复杂等缺陷,提供了一种利用高效液相色谱分离法获得高纯度、高稳定性、回收率高、便于规模化生产的氯胺酮标准物质制备方法。It overcomes the defects of low purity, poor stability, poor uniformity, and complicated preparation process of the ketamine sample obtained by the preparation and purification method of the prior art, and provides a high-purity, high-stability, high-recovery method that utilizes high-performance liquid chromatography separation method to obtain The preparation method of the ketamine standard substance is high and convenient for large-scale production.
附图说明Description of drawings
下面结合附图对本发明的具体实施方式作进一步详细的说明。The specific implementation manners of the present invention will be further described in detail below in conjunction with the accompanying drawings.
图1-1杂质1的紫外光谱图;图1-2氯胺酮的紫外光谱图;图1-3杂质2的紫外光谱图;Figure 1-1 UV spectrum of impurity 1; Figure 1-2 UV spectrum of ketamine; Figure 1-3 UV spectrum of impurity 2;
图2氯胺酮样品反相HPLC色谱图;乙腈-磷酸盐缓冲液(二者体积比为25:75);Fig. 2 ketamine sample reversed-phase HPLC chromatogram; Acetonitrile-phosphate buffer saline (both volume ratios are 25:75);
图3氯胺酮样品反相HPLC色谱图;甲醇-0.05%TFA水(二者体积比为35:65);Fig. 3 ketamine sample reverse-phase HPLC chromatogram; Methanol-0.05% TFA water (both volume ratios are 35:65);
图4氯胺酮样品反相HPLC色谱图;乙腈-0.05%TFA水(二者体积比为33:67);Fig. 4 ketamine sample reverse-phase HPLC chromatogram; Acetonitrile-0.05% TFA water (both volume ratios are 33:67);
图5氯胺酮样品制备HPLC色谱图(甲醇:0.05%TFA/水=20:80,体积比);Fig. 5 Ketamine sample preparation HPLC chromatogram (methanol: 0.05% TFA/water=20:80, volume ratio);
图6氯胺酮的反相HPLC色谱图(甲醇:0.05%TFA/水=33:67,体积比);The reverse phase HPLC chromatogram of Fig. 6 ketamine (methanol:0.05%TFA/water=33:67, volume ratio);
图7氯胺酮制备液相色谱图甲醇/水(二者体积比为40:60),10mL/min,210nm;Figure 7 Ketamine preparation liquid chromatogram Methanol/water (both volume ratio is 40:60), 10mL/min, 210nm;
图8氯胺酮制备液相色谱图甲醇/水(二者体积比为40:60),8mL/min,210nm;Figure 8 Ketamine preparation liquid chromatogram Methanol/water (both volume ratio is 40:60), 8mL/min, 210nm;
图9氯胺酮制备液相色谱图甲醇/水(二者体积比为30:70),10mL/min;Figure 9 Ketamine preparation liquid chromatogram Methanol/water (both volume ratio is 30:70), 10mL/min;
图10氯胺酮制备液相色谱图甲醇/水(二者体积比为30:70),8mL/min;Figure 10 Ketamine preparation liquid chromatogram Methanol/water (both volume ratio is 30:70), 8mL/min;
图11氯胺酮的反相HPLC色谱图(甲醇:0.05%TFA/水=35:65,体积比);The reverse phase HPLC chromatogram of Fig. 11 ketamine (methanol: 0.05% TFA/water=35:65, volume ratio);
图12氯胺酮标准物质的纯化制备方法流程图;The flow chart of the purification preparation method of Fig. 12 ketamine standard substance;
图13氯胺酮的氢谱图;图14氯胺酮的碳谱图;The hydrogen spectrogram of Fig. 13 ketamine; The carbon spectrogram of Fig. 14 ketamine;
图15盐酸氯胺酮样品质谱图;图16盐酸氯胺酮的红外谱图;Fig. 15 ketamine hydrochloride sample mass spectrogram; Fig. 16 the infrared spectrum of ketamine hydrochloride;
图17盐酸氯胺酮的气质谱图;图18氯胺酮的GC/MS总离子流图The gas spectrogram of Fig. 17 ketamine hydrochloride; The GC/MS total ion chromatogram of Fig. 18 ketamine
图19羟亚胺质谱图。Figure 19 Hydroxylimine mass spectrum.
具体实施方式Detailed ways
为了更清楚地说明本发明,下面结合优选实施例和附图对本发明做进一步的说明。附图中相似的部件以相同的附图标记进行表示。本领域技术人员应当理解,下面所具体描述的内容是说明性的而非限制性的,不应以此限制本发明的保护范围。In order to illustrate the present invention more clearly, the present invention will be further described below in conjunction with preferred embodiments and accompanying drawings. Similar parts in the figures are denoted by the same reference numerals. Those skilled in the art should understand that the content specifically described below is illustrative rather than restrictive, and should not limit the protection scope of the present invention.
本实施例主要是利用案件鉴定后剩余的氯胺酮晶体样本,对利用制备液相色谱法分离纯化制备氯胺酮的实验条件进行了优化筛选。This example mainly utilizes the remaining ketamine crystal samples after case identification to optimize and screen the experimental conditions for separation and purification of ketamine by preparative liquid chromatography.
一、仪器、试剂及材料1. Instruments, reagents and materials
1.1主要仪器1.1 Main Instruments
分析型高效液相色谱仪(日本岛津),包括:LC-20AD高压输液泵;SIL-10A自动进样器;SPD-20A二极管阵列检测器;CTO-20A柱温箱。Analytical high-performance liquid chromatography (Shimadzu, Japan), including: LC-20AD high-pressure infusion pump; SIL-10A autosampler; SPD-20A diode array detector; CTO-20A column thermostat.
制备型高效液相色谱仪(Agilent),包括:G1361A高压输液泵;G2260A自动进样器;G1315D二极管阵列检测器;G1364B自动馏分收集器。Preparative high-performance liquid chromatography (Agilent), including: G1361A high-pressure infusion pump; G2260A automatic sampler; G1315D diode array detector; G1364B automatic fraction collector.
BUCHI旋转蒸发器(日本BUCHI公司);KQ3200型超声波清洗器(昆山市超声仪器有限公司);飞鸽牌TDL-40B台式离心机(上海安亭科学仪器厂);XS105Dual Range电子天平(瑞士METTLER TOLEDO公司)。BUCHI rotary evaporator (Japan BUCHI company); KQ3200 ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); Feige brand TDL-40B desktop centrifuge (Shanghai Anting Scientific Instrument Factory); XS105Dual Range electronic balance (Switzerland METTLER TOLEDO company).
1.2主要试剂及材料1.2 Main reagents and materials
甲醇(色谱纯,美国Fisher Scientific公司),三氟乙酸(色谱纯,中国百灵威公司),超纯水(经Millipore超纯水制备系统净化,法国Millipore公司)。氯胺酮1mg/mL标准溶液(中国百灵威公司);氯胺酮样品(白色粉末)由案件缴获并应用于本研究中。Methanol (chromatographically pure, Fisher Scientific, USA), trifluoroacetic acid (chromatographically pure, China Bailingwei Company), ultrapure water (purified by Millipore ultrapure water preparation system, Millipore, France). Ketamine 1mg/mL standard solution (China Bailingwei Company); ketamine sample (white powder) was seized by the case and used in this study.
二、缴获氯胺酮样品中氯胺酮的纯度测定及氯胺酮标准物质的纯化制备2. Determination of the purity of ketamine in the seized ketamine samples and purification and preparation of ketamine standard substances
2.1样品溶液的制备2.1 Preparation of sample solution
分析型:1.0mg氯胺酮样品溶于1mL甲醇中,配成1.0mg/mL氯胺酮样品溶液用于定性及定量分析,使用前样品溶液经过0.45μm微孔滤膜过滤。Analytical type: Dissolve 1.0mg ketamine sample in 1mL methanol to prepare 1.0mg/mL ketamine sample solution for qualitative and quantitative analysis. Before use, the sample solution is filtered through a 0.45μm microporous membrane.
制备型样品溶液一:3.369g氯胺酮样品先溶于10mL甲醇中,充分溶解后离心,过滤去除沉淀,有机相取出,离心浓缩至干,加水定容至10mL,配成氯胺酮样品溶液用于制备型高效液相色谱分离制备氯胺酮标准品。使用前样品溶液均经过0.45μm微孔滤膜过滤。Preparative sample solution 1: Dissolve 3.369g ketamine sample in 10mL methanol first, centrifuge after fully dissolving, filter to remove precipitate, take out the organic phase, concentrate to dryness by centrifugation, add water to make up to 10mL, and prepare ketamine sample solution for preparative sample solution Preparation of Ketamine Standards by High Performance Liquid Chromatography. The sample solution was filtered through a 0.45 μm microporous membrane before use.
制备型样品溶液二:称取氯胺酮样品3368.51mg(相当于纯氯胺酮1999.548mg)于50mL容量瓶内,加水定容至刻度。配制成氯胺酮含量为40mg/mL的样品水溶液,用于制备型高效液相色谱分离制备氯胺酮标准品,使用前经过0.22um混合膜过滤。Preparative sample solution 2: Weigh 3368.51mg of ketamine sample (equivalent to 1999.548mg of pure ketamine) into a 50mL volumetric flask, add water to make up to the mark. Prepare a sample aqueous solution with a ketamine content of 40mg/mL, which is used for preparative high-performance liquid chromatography to separate and prepare ketamine standard products, and is filtered through a 0.22um mixed membrane before use.
2.2液相色谱条件2.2 Liquid chromatography conditions
2.2.1反相高效液相色谱(RP-HPLC)分析方法:2.2.1 Reversed phase high performance liquid chromatography (RP-HPLC) analysis method:
色谱条件一:色谱柱为Shim-pack HRC-ODS柱(250mm×4.6mm I.D.,5μm);流动相为甲醇:0.05%三氟乙酸/水=35:65(体积比,0.05%三氟乙酸/水是指三氟乙酸体积分数为0.05%的三氟乙酸水溶液),等度洗脱;紫外检测波长210nm;流速1.0mL/min;柱温35℃。Chromatographic condition one: the chromatographic column is a Shim-pack HRC-ODS column (250mm×4.6mm I.D., 5μm); the mobile phase is methanol: 0.05% trifluoroacetic acid/water=35:65 (volume ratio, 0.05% trifluoroacetic acid/ Water refers to a trifluoroacetic acid aqueous solution with a volume fraction of 0.05% trifluoroacetic acid), isocratic elution; ultraviolet detection wavelength 210nm; flow rate 1.0mL/min; column temperature 35°C.
色谱条件二:色谱柱为Shim-pack HRC-ODS柱(250mm×4.6mm I.D.,5μm);流动相为甲醇:0.05%三氟乙酸/水=33:67(体积比,0.05%三氟乙酸/水是指三氟乙酸体积分数为0.05%的三氟乙酸水溶液),等度洗脱;紫外检测波长210nm;流速1.0mL/min;柱温35℃。Chromatographic condition two: the chromatographic column is a Shim-pack HRC-ODS column (250mm×4.6mm I.D., 5μm); the mobile phase is methanol: 0.05% trifluoroacetic acid/water=33:67 (volume ratio, 0.05% trifluoroacetic acid/ Water refers to a trifluoroacetic acid aqueous solution with a volume fraction of 0.05% trifluoroacetic acid), isocratic elution; ultraviolet detection wavelength 210nm; flow rate 1.0mL/min; column temperature 35°C.
2.2.2反相高效液相色谱(RP-HPLC)制备方法:2.2.2 Reversed phase high performance liquid chromatography (RP-HPLC) preparation method:
色谱条件一:色谱柱为Shim-pack VP-ODS制备柱(250mm×20mm I.D.,15μm);流动相为甲醇:水=30:70(体积比),等度洗脱;紫外检测波长210nm;流速8mL/min;上样量700μL;柱温为室温。Chromatographic condition 1: Chromatographic column is Shim-pack VP-ODS preparative column (250mm×20mm I.D., 15μm); mobile phase is methanol: water = 30:70 (volume ratio), isocratic elution; UV detection wavelength 210nm; flow rate 8mL/min; sample volume 700μL; column temperature is room temperature.
色谱条件二:色谱柱为Shim-pack VP-ODS制备柱(250mm×20mm I.D.,15μm);流动相为甲醇:0.05%三氟乙酸/水=20:80(体积比),等度洗脱;紫外检测波长210nm;流速8mL/min;上样量500μL;柱温为室温。Chromatographic condition two: the chromatographic column is a Shim-pack VP-ODS preparative column (250mm×20mm I.D., 15μm); the mobile phase is methanol: 0.05% trifluoroacetic acid/water = 20:80 (volume ratio), isocratic elution; The ultraviolet detection wavelength is 210nm; the flow rate is 8mL/min; the sample volume is 500μL; the column temperature is room temperature.
2.3高效液相色谱分析条件的优化2.3 Optimization of HPLC analysis conditions
2.3.1色谱柱的选择2.3.1 Selection of chromatographic column
本实验采用的反相色谱柱为Shim-pack HRC-ODS柱(250mm×4.6mm I.D.,5μm)。The reverse-phase chromatographic column used in this experiment is Shim-pack HRC-ODS column (250mm×4.6mm I.D., 5μm).
2.3.2检测波长的选择2.3.2 Selection of detection wavelength
结合盐酸氯胺酮及杂质的紫外吸收图(如图1-1、图1-2和图1-3所示),比较了检测波长为210nm,220nm,230nm、240nm、254nm下主成分与杂质响应差异,综合比较分析基线噪声、检测灵敏度和结果稳定性数据,确定选择210nm作为定值和检测波长。Combined with the ultraviolet absorption diagrams of ketamine hydrochloride and impurities (as shown in Figure 1-1, Figure 1-2 and Figure 1-3), the difference in response between the main component and the impurity at the detection wavelengths of 210nm, 220nm, 230nm, 240nm, and 254nm was compared , comprehensively compared and analyzed the baseline noise, detection sensitivity and result stability data, and determined to select 210nm as the fixed value and detection wavelength.
2.3.3流动相体系的选择2.3.3 Selection of mobile phase system
关于反相色谱流动相体系的选择,试验比较了几种不同的流动相乙腈-磷酸盐缓冲液、甲醇-磷酸盐缓冲液、乙腈-0.05%TFA水溶液【0.05%TFA水溶液是指三氟乙酸体积分数为0.05%的三氟乙酸水溶液】、甲醇-0.05%TFA水溶液【0.05%TFA水溶液是指三氟乙酸体积分数为0.05%的三氟乙酸水溶液】及甲醇-水体系对氯胺酮和杂质的色谱分离度、峰形和保留时间等的影响。结果表明,采用乙腈-磷酸盐缓冲液(体积比为25:75)、甲醇-0.05%TFA水(体积比为35:65)以及乙腈-0.05%TFA水(体积比为33:67),样品中的氯胺酮组分与其中的杂质成分均能得到较好的分离,并且拖尾小,出峰时间快,而甲醇-水体系中氯胺酮色谱峰严重拖尾,因此该体系不适用于对氯胺酮样品中的各组分进行分离。试验考虑到缓冲盐会缩短色谱柱的使用寿命,乙腈毒性大且使试验成本增加,因此综合考虑选择流动相体系为甲醇-0.05%TFA水(二者体积比为35:65)体系。各流动相体系下氯胺酮样品的液相色谱图见图2、图3和图4所示。Regarding the selection of the reversed-phase chromatography mobile phase system, the test compared several different mobile phases: acetonitrile-phosphate buffer saline, methanol-phosphate buffer, acetonitrile-0.05% TFA aqueous solution [0.05% TFA aqueous solution refers to the volume of trifluoroacetic acid Chromatographic separation of ketamine and impurities in 0.05% trifluoroacetic acid aqueous solution], methanol-0.05% TFA aqueous solution [0.05% TFA aqueous solution refers to trifluoroacetic acid aqueous solution with a volume fraction of 0.05% trifluoroacetic acid] and methanol-water system Influence of degree, peak shape and retention time etc. The results showed that the sample The ketamine component and the impurity components in it can be well separated, and the tailing is small, and the peak time is fast, but the ketamine chromatographic peak in the methanol-water system is severely tailed, so this system is not suitable for ketamine samples. The components in are separated. The test considers that the buffer salt will shorten the service life of the chromatographic column, and the toxicity of acetonitrile will increase the cost of the test. Therefore, the mobile phase system is selected as methanol-0.05% TFA water (the volume ratio of the two is 35:65) system. The liquid chromatograms of ketamine samples under various mobile phase systems are shown in Figure 2, Figure 3 and Figure 4.
2.3.4标准曲线和线性关系2.3.4 Standard curve and linear relationship
用色谱甲醇稀释氯胺酮标准储备液,精密配制成浓度分别为0.5、1、5、10、50、100、500、1000μg/mL的氯胺酮对照品溶液,按反相色谱条件测定,每个浓度重复3次,以平均值计算,记录氯胺酮色谱峰面积,以对照品的进样浓度(μg/mL)为横坐标,色谱峰面积值为纵坐标作图,并计算标准曲线的回归方程。Dilute the ketamine standard stock solution with chromatographic methanol, and precisely prepare ketamine reference substance solutions with concentrations of 0.5, 1, 5, 10, 50, 100, 500, and 1000 μg/mL, and measure according to reversed-phase chromatography conditions, and repeat 3 times for each concentration. Times, calculated as the average value, record the ketamine chromatographic peak area, take the injection concentration (μg/mL) of the reference substance as the abscissa, and the chromatographic peak area value as the ordinate to plot, and calculate the regression equation of the standard curve.
表1氯胺酮的浓度与峰面积The concentration and peak area of table 1 ketamine
以峰面积对浓度作图,标准曲线的回归方程为:The peak area is plotted against the concentration, and the regression equation of the standard curve is:
Y=3×107X+92617,R2=0.9999……………………Y=3×10 7 X+92617, R 2 =0.9999……………………
表明氯胺酮在0.5--1000μg/mL的范围内线性关系良好。It shows that ketamine has a good linear relationship in the range of 0.5--1000μg/mL.
2.3.5样品中氯胺酮含量的测定2.3.5 Determination of ketamine content in samples
按反相色谱方法分析测定浓度为1.0mg/mL的氯胺酮样品溶液,重复测定3次,记录氯胺酮峰面积,计算其平均值,按峰面积外标法计算样品中的氯胺酮含量。Analyze and measure the ketamine sample solution with a concentration of 1.0 mg/mL according to the reversed-phase chromatography method, repeat the measurement 3 times, record the peak area of ketamine, calculate its average value, and calculate the content of ketamine in the sample according to the external standard method of peak area.
表2样品中氯胺酮含量的测定结果The assay result of ketamine content in the sample of table 2
由表2可知,通过峰面积外标法由标准曲线方程计算得到1.0mg/mL的氯胺酮样品溶液中盐酸氯胺酮的含量为0.5936mg/mL,进而求得氯胺酮样品中盐酸氯胺酮的纯度为59.36wt%。It can be seen from Table 2 that the content of ketamine hydrochloride in the ketamine sample solution of 1.0mg/mL is calculated as 0.5936mg/mL by the standard curve equation through the peak area external standard method, and then the purity of ketamine hydrochloride in the ketamine sample is obtained as 59.36wt%. .
2.3.6高效液相色谱制备条件的优化2.3.6 Optimization of HPLC preparation conditions
采用甲醇-TFA水体系来分离氯胺酮样品中的氯胺酮组分(采用制备型样品溶液二和色谱条件二),试验表明采用与分析条件中相同的流动相配比使杂质成分与氯胺酮组分相互叠加,使杂质成分不能够与氯胺酮组分分离,通过对甲醇比例的调节,最终氯胺酮与其他组分达到了较好的分离效果,制备液相谱图如图5所示。将收集到的馏分进一步纯化:氯胺酮样品中氯胺酮是以盐酸盐的形式存在的,经制备液相分离后馏分经过离心浓缩或旋转蒸发后去除甲醇,但不能将馏分中残留的三氟乙酸除去,为了获得最终的制备产物氯胺酮盐酸盐,需经过进一步的纯化处理。经旋蒸除去甲醇后,将剩余的水液pH调至11,以色谱纯氯仿多次反复提取,合并有机相后,离心浓缩至出现白色沉淀,向其中注入水分,缓慢加入0.1N盐酸至水液pH为5-6,去除其中有机相,水相冷冻干燥后即可获得盐酸氯胺酮晶体。其HPLC色谱图如图6所示。经HPLC分析,峰面积归一化法测定百分含量,氯胺酮含量99.72wt%。The methanol-TFA water system is used to separate the ketamine components in the ketamine sample (preparative sample solution two and chromatographic condition two), and the test shows that the impurity components and the ketamine components are superimposed on each other by using the same mobile phase ratio as in the analysis conditions, The impurity components could not be separated from the ketamine components, and by adjusting the proportion of methanol, a better separation effect was finally achieved between ketamine and other components, and the prepared liquid chromatogram is shown in Figure 5. Further purification of the collected fractions: Ketamine exists in the form of hydrochloride in the ketamine sample. After the separation of the liquid phase, the fractions are centrifugally concentrated or rotary evaporated to remove methanol, but the residual trifluoroacetic acid in the fractions cannot be removed. , in order to obtain the final preparation product ketamine hydrochloride, further purification treatment is required. After the methanol was removed by rotary evaporation, the pH of the remaining water was adjusted to 11, and the chromatographically pure chloroform was repeatedly extracted. After the organic phase was combined, it was concentrated by centrifugation until a white precipitate appeared, and water was injected into it, and 0.1N hydrochloric acid was slowly added to the water. The pH of the solution is 5-6, the organic phase is removed, and the water phase is freeze-dried to obtain ketamine hydrochloride crystals. Its HPLC chromatogram is shown in Figure 6. After HPLC analysis, the percentage content was determined by the peak area normalization method, and the ketamine content was 99.72wt%.
上面利用甲醇-三氟乙酸水体系分离制备氯胺酮标准物质在馏分的二次纯化过程中,需要对馏分进行旋蒸后再调碱性条件用有机溶剂反提,组分进行盐酸化才能获得氯胺酮盐酸盐,操作过程复杂,引入杂质的机会增多,因此,进一步对制备条件进行了改善,尝试使用甲醇-水体系分离制备氯胺酮组分(采用制备型样品溶液一和色谱条件一)。In the secondary purification process of the distillate, the distillate needs to be rotary-evaporated and then adjusted to alkaline conditions, back-extracted with an organic solvent, and the components are hydrochloricized to obtain ketamine salt. salt, the operation process is complicated, and the chance of introducing impurities increases. Therefore, the preparation conditions are further improved, and the methanol-water system is used to separate and prepare ketamine components (using preparative sample solution 1 and chromatographic condition 1).
试验证明,采用甲醇-水体系不适用于分析氯胺酮样品,但同时也发现在该体系作为流动相时全部组分都能够被洗脱出来,因此尝试了甲醇-水体系在制备液相上对氯胺酮的分离效果。由实验结果可知,当流动相组成为甲醇:水(体积比为40:60),流速为10mL/min时,氯胺酮能够与其后面的杂质成分完全分开,但同其前面的杂质同时出峰;进一步降低流速,流动相组成不变,在8mL/min条件下进行分离,氯胺酮与其前面杂质的分离状况并未得到改善。制备液相色谱图见图7和图8。Tests have proved that the methanol-water system is not suitable for analyzing ketamine samples, but it is also found that all components can be eluted when the system is used as the mobile phase. separation effect. As can be seen from the experimental results, when the mobile phase is composed of methanol: water (volume ratio is 40:60), and when the flow rate is 10mL/min, ketamine can be completely separated from the impurity components behind it, but peaks simultaneously with the impurities in front of it; further The flow rate was reduced, the composition of the mobile phase remained unchanged, and the separation was carried out under the condition of 8mL/min, and the separation status of ketamine and its previous impurities was not improved. The preparative liquid chromatograms are shown in Figure 7 and Figure 8.
降低流动相中甲醇比例,当流动相组成为甲醇/水(体积比为30:70),流速为10mL/min即可获得较好的分离效果。氯胺酮与其前后的杂质成分均达到较好的分离。考虑到流速高时色谱柱压力增大,因此为有效延长色谱柱使用寿命,将流速降低,在流速为8mL/min条件下实验,仍获得较好的分离效果,各组分流出色谱柱的时间增加了大约6min。实验最终选定分离条件为甲醇:水(体积比为30:70),流速8mL/min。制备液相色谱图见图9-图10。Reduce the proportion of methanol in the mobile phase. When the mobile phase is composed of methanol/water (volume ratio 30:70), a better separation effect can be obtained at a flow rate of 10mL/min. Ketamine and its impurity components before and after achieved good separation. Considering that the pressure of the chromatographic column increases when the flow rate is high, in order to effectively prolong the service life of the chromatographic column, the flow rate is reduced. In the experiment at a flow rate of 8mL/min, a good separation effect is still obtained. The time for each component to flow out of the chromatographic column Added about 6 minutes. The final selected separation condition of the experiment was methanol: water (volume ratio 30:70), flow rate 8mL/min. The preparative liquid chromatograms are shown in Figure 9-Figure 10.
2.4批处理程序2.4 Batch processing program
由于经过试验考察,在所采用的制备液相色谱条件下(采用制备型样品溶液一和色谱条件一),20min内氯胺酮组分就能从制备柱中被洗脱出来,但后面的杂质出峰太晚使分离时间延长。又由于制备分离的流动相体系是由甲醇和水组成,当水与甲醇混合时,将出现放热现象,混合溶剂体积减小,同时有大量气泡释放。因此,试验采用进泵前将甲醇和水(体积比为30:70)按比例混合,充分混匀脱气后使用,制备方法运行20分钟后以100%甲醇冲洗色谱柱,使残留在柱中的杂质成分迅速被洗脱。建立的批处理程序为以下三个步骤按顺序多次循环,即:首先甲醇冲洗色谱柱,之后流动相平衡色谱柱,然后运行制备方法。Due to the experimental investigation, under the adopted preparative liquid chromatographic conditions (using preparative sample solution one and chromatographic condition one), the ketamine component can be eluted from the preparative column within 20min, but the impurities behind come out of the peak Too late prolongs the separation time. And because the mobile phase system for preparing separation is composed of methanol and water, when water and methanol are mixed, exothermic phenomenon will occur, the volume of the mixed solvent will decrease, and a large number of bubbles will be released simultaneously. Therefore, before the test, methanol and water (volume ratio is 30:70) were mixed in proportion before entering the pump, and used after fully mixing and degassing. After the preparation method was run for 20 minutes, the chromatographic column was rinsed with 100% methanol to make the residue in the column Impurities are quickly eluted. The batch procedure was established as multiple cycles of the following three steps in sequence, first flushing the column with methanol, then equilibrating the column with the mobile phase, and then running the preparative method.
氯胺酮样品中氯胺酮是以盐酸盐的形式存在的,经制备液相分离后馏分中仍为氯胺酮盐酸盐,需经过进一步的纯化处理。经旋蒸后将馏分中的甲醇成分去除,冷冻干燥并真空脱水后即可获得盐酸氯胺酮晶体。其HPLC色谱图如图11所示。Ketamine in the ketamine sample exists in the form of hydrochloride, and the distillate after liquid phase separation is still ketamine hydrochloride, which needs to be further purified. Ketamine hydrochloride crystals can be obtained after rotary evaporation to remove the methanol component in the fraction, freeze-drying and vacuum dehydration. Its HPLC chromatogram is shown in Figure 11.
2.5制备得到的氯胺酮标准物质的结构确证2.5 Confirmation of the structure of the prepared ketamine standard substance
2.5.1核磁共振分析2.5.1 NMR analysis
为了确定制备液相分离所得到的化合物的结构,进行了核磁共振分析,谱图见图13-14。In order to determine the structure of the compound obtained by the preparative liquid phase separation, nuclear magnetic resonance analysis was carried out, and the spectra are shown in Figures 13-14.
溶剂:D2OSolvent: D2O
2.5.2液相色谱-串联质谱联用法2.5.2 Liquid chromatography-tandem mass spectrometry
在ESI正离子模式下,破碎电压80V,碰撞能8eV,样品的质谱图如图15所示。从质谱图中可以得到下列信息:In the ESI positive ion mode, the fragmentation voltage is 80V, and the collision energy is 8eV. The mass spectrum of the sample is shown in FIG. 15 . The following information can be obtained from the mass spectrum:
准分子离子峰[M+H]+的m/z238.20,与氯胺酮的相对分子质量237.72g/mol相差1,因而检测样品的分子量与氯胺酮的相符。The m/z of the quasi-molecular ion peak [M+H]+ is 238.20, and the relative molecular mass of ketamine is 237.72g/mol. The difference is 1, so the molecular weight of the detected sample is consistent with that of ketamine.
2.5.3红外光谱法2.5.3 Infrared spectroscopy
在AVATAR 330FT-IR红外光谱仪(Thermo Nicolet公司)上测定了氯胺酮的红外光谱,如图16,结果与NIST谱图库中标准谱图一致。The infrared spectrum of ketamine was measured on the AVATAR 330FT-IR infrared spectrometer (Thermo Nicolet Company), as shown in Figure 16, and the result was consistent with the standard spectrum in the NIST spectral library.
2.5.4气相色谱-质谱法2.5.4 Gas chromatography-mass spectrometry
气相色谱-质谱法得到的谱图(图17)与氯胺酮的标准谱图是一致的。The spectrogram obtained by gas chromatography-mass spectrometry ( FIG. 17 ) is consistent with the standard spectrogram of ketamine.
由于在气相色谱分析中存在一个较大的杂质,其含量为0.4%。因此利用气相色谱-质谱法对其进行了分析。根据仪器所测得的质谱图分析(图18),主要杂质为羟亚胺。羟亚胺主要用作医药中间体,是合成氯胺酮的重要中间体,咖啡色和乳白色粉末状。在2008年被列入“易制毒化学品管理条例”。CAS号90717-16-1。Due to the presence of a larger impurity in gas chromatographic analysis, its content was 0.4%. Therefore, it was analyzed by gas chromatography-mass spectrometry. According to the mass spectrogram analysis (Figure 18) measured by the instrument, the main impurity is hydroxylimine. Hydroxyimine is mainly used as a pharmaceutical intermediate, an important intermediate for the synthesis of ketamine, in the form of brown and milky white powder. In 2008, it was included in the "Regulations on the Administration of Precursor Chemicals". CAS number 90717-16-1.
2.6所得氯胺酮标准物质的纯度测定结果2.6 The purity measurement result of gained ketamine standard substance
经HPLC、GC以及QNMR方法定值分析,制备的盐酸氯胺酮标准物质的纯度为99.47wt%,扩展不确定度为0.62%(k=2)。均匀性良好,稳定性至少1年以上。The purity of the prepared ketamine hydrochloride standard substance was 99.47wt% and the expanded uncertainty was 0.62% (k=2) through HPLC, GC and QNMR methods. The uniformity is good, and the stability is at least 1 year.
显然,本发明的上述实施例仅仅是为清楚地说明本发明所作的举例,而并非是对本发明的实施方式的限定,对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动,这里无法对所有的实施方式予以穷举,凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。Apparently, the above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, and are not intended to limit the implementation of the present invention. Those of ordinary skill in the art can also make It is impossible to exhaustively list all the implementation modes here, and any obvious changes or changes derived from the technical solutions of the present invention are still within the scope of protection of the present invention.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710316040.0A CN107478757B (en) | 2017-05-08 | 2017-05-08 | Purification and preparation method of ketamine standard substance for forensic drug detection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710316040.0A CN107478757B (en) | 2017-05-08 | 2017-05-08 | Purification and preparation method of ketamine standard substance for forensic drug detection |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107478757A CN107478757A (en) | 2017-12-15 |
CN107478757B true CN107478757B (en) | 2019-12-06 |
Family
ID=60594377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710316040.0A Active CN107478757B (en) | 2017-05-08 | 2017-05-08 | Purification and preparation method of ketamine standard substance for forensic drug detection |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107478757B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103808846A (en) * | 2014-02-20 | 2014-05-21 | 福建国际旅行卫生保健中心 | Series quadrupole-rod gas-chromatographic mass spectrometry detection method for 35 toxic medicaments in urine |
CN103823008A (en) * | 2014-03-14 | 2014-05-28 | 北京市疾病预防控制中心 | Method for detecting unknown poison by establishing liquid chromatography-mass spectrometry database |
CN103896898A (en) * | 2014-03-07 | 2014-07-02 | 中国计量科学研究院 | Naringenin standard substance as well as preparation and application thereof |
CN105717240A (en) * | 2016-03-24 | 2016-06-29 | 中国标准化研究院 | Method for preparing Alitame standard substance |
CN106442034A (en) * | 2016-03-24 | 2017-02-22 | 中国标准化研究院 | 2, 4-dichlorophenoxyacetic acid standard substance preparation method and application thereof |
JP2019066360A (en) * | 2017-10-02 | 2019-04-25 | 国立研究開発法人農業・食品産業技術総合研究機構 | Method and system for analyzing procyanidins |
-
2017
- 2017-05-08 CN CN201710316040.0A patent/CN107478757B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103808846A (en) * | 2014-02-20 | 2014-05-21 | 福建国际旅行卫生保健中心 | Series quadrupole-rod gas-chromatographic mass spectrometry detection method for 35 toxic medicaments in urine |
CN103896898A (en) * | 2014-03-07 | 2014-07-02 | 中国计量科学研究院 | Naringenin standard substance as well as preparation and application thereof |
CN103823008A (en) * | 2014-03-14 | 2014-05-28 | 北京市疾病预防控制中心 | Method for detecting unknown poison by establishing liquid chromatography-mass spectrometry database |
CN105717240A (en) * | 2016-03-24 | 2016-06-29 | 中国标准化研究院 | Method for preparing Alitame standard substance |
CN106442034A (en) * | 2016-03-24 | 2017-02-22 | 中国标准化研究院 | 2, 4-dichlorophenoxyacetic acid standard substance preparation method and application thereof |
JP2019066360A (en) * | 2017-10-02 | 2019-04-25 | 国立研究開発法人農業・食品産業技術総合研究機構 | Method and system for analyzing procyanidins |
Non-Patent Citations (6)
Title |
---|
Determination of ketamine and norketamine enantiomers in plasma by solid-phase extraction and high-performance liquid chromatography;Jan-Olof Svensson 等;《Journal of Chromatography B》;19960412;第678卷(第2期);第373-376 * |
Se'bastien Bolze 等.HPLC determination of ketamine, norketamine,and dehydronorketamine in plasma with a high-purity reversed-phase sorbent.《Clinical Chemistry》.1998,第44卷(第3期), * |
Simultaneous determination of ketamine and xylazine in canine plasma by liquid chromatography with ultraviolet absorbance detection;Frank Niedorf 等;《Journal of Chromatography B》;20030705;第791卷(第1-2期);第421-426页 * |
二乙酰吗啡盐酸盐标准物质的研制(1)——均匀性和稳定性检验;冯超 等;《刑事技术》;20131231(第4期);第20-24页 * |
人血中级胺酮的高效液相色谱法测定;陈弘博 等;《中国医院药学杂志》;19911231;第11卷(第10期);第439-440页 * |
高效液相色谱法测定血中氯胺酮浓度的改进;张金玲;《中国医院药学杂志》;20001231;第20卷(第1期);第11-12页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107478757A (en) | 2017-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104428664B (en) | Improvement Analysis method for analyzing and measuring the impurity in dianhydrogalactitol | |
CN107192596A (en) | Method for preparing purified for the THC standard substance of forensic science illicit drugs inspection | |
CN103048401A (en) | Determining method for 15 kinds of forbidden nitro imidazoles antibiotics in cosmetics | |
JP2015508174A5 (en) | ||
CN107345946B (en) | The method for preparing purified of methcathinone standard substance for forensic science illicit drugs inspection | |
Chen et al. | Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies | |
CN107478755A (en) | Method for preparing purified for the crystal methamphetamine standard substance of forensic science illicit drugs inspection | |
Shi et al. | Targeted metabolomics assisted rapid screening and characterization of aristolochic acids and their DNA adducts in aristolochia plants by ultra-high performance liquid chromatography coupled with ion mobility quadrupole time-of-flight mass spectrometry | |
CN102020691A (en) | High performance liquid chromatographic separation method of four monomer components of aescine | |
Liu et al. | Development and validation of liquid chromatography–tandem mass spectrometry method for simultaneous determination of six steroidal saponins in rat plasma and its application to a pharmacokinetics study | |
Liu et al. | Quantitative analysis of chemical constituents in different commercial parts of Notopterygium incisum by HPLC–DAD–MS | |
Zhao et al. | Rapid resolution liquid chromatography–mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4, 6, 8 (14), 22-tetraen-3-one | |
Dong et al. | Effect of inorganic salt on partition of high‐polarity parishins in two‐phase solvent systems and separation by high‐speed counter‐current chromatography from Gastrodia elata Blume | |
Luan et al. | Determination of Raddeanin A in rat plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study | |
CN111747914A (en) | Compound isolated from ginkgo root bark and use thereof | |
CN107478757B (en) | Purification and preparation method of ketamine standard substance for forensic drug detection | |
CN107383032A (en) | For the morphine base of forensic science illicit drugs inspection, morphine hydrochloride, heroin hydrochloride standard substance method for preparing purified | |
CN107478733A (en) | Method for preparing purified for the codeine standard substance of forensic science illicit drugs inspection | |
CN113624881B (en) | A method for simultaneously detecting the content of six components in Sanwu Capsules | |
Liu et al. | Metabolomic study of a rat fever model induced with 2, 4-dinitrophenol and the therapeutic effects of a crude drug derived from Coptis chinensis | |
CN107340347B (en) | Purification and preparation method of pethidine standard substance used for forensic drug detection | |
CN107179361B (en) | Purification and preparation method of methadone standard substance for forensic drug detection | |
CN107101864A (en) | Method for preparing purified for the cocainehydrochloride standard substance of forensic science illicit drugs inspection | |
CN107179360A (en) | Method for preparing purified for the triazolam standard substance of forensic science illicit drugs inspection | |
CN105334273A (en) | Quality control method of anisetree bark |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |